TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 181.9M
Gross Profit 61.5M 33.82%
Operating Income 25.5M 14.05%
Net Income 18.0M 9.90%
EPS (Diluted) $2.62

Balance Sheet Metrics

Total Assets 590.4M
Total Liabilities 363.1M
Shareholders Equity 227.3M
Debt to Equity 1.60

Cash Flow Metrics

Operating Cash Flow -80.8M
Free Cash Flow -81.0M

Revenue & Profitability Trend

CRA International Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i687.4M624.0M590.9M565.9M508.4M
Cost of Goods Sold i479.9M439.8M410.1M400.1M370.7M
Gross Profit i207.5M184.2M180.8M165.9M137.7M
Gross Margin % i30.2%29.5%30.6%29.3%27.1%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i125.0M115.1M110.1M97.4M90.0M
Other Operating Expenses i-----
Total Operating Expenses i125.0M115.1M110.1M97.4M90.0M
Operating Income i70.8M57.5M58.7M55.7M34.8M
Operating Margin % i10.3%9.2%9.9%9.8%6.8%
Non-Operating Items
Interest Income i-----
Interest Expense i4.4M3.8M1.8M970.0K1.2M
Other Non-Operating Income-92.0K-1.4M1.9M-494.0K42.0K
Pre-tax Income i66.2M52.3M58.8M54.3M33.6M
Income Tax i19.6M13.8M15.2M12.6M9.1M
Effective Tax Rate % i29.6%26.4%25.8%23.2%27.1%
Net Income i46.7M38.5M43.6M41.7M24.5M
Net Margin % i6.8%6.2%7.4%7.4%4.8%
Key Metrics
EBITDA i97.6M83.4M84.5M81.5M59.7M
EPS (Basic) i$6.82$5.48$6.02$5.59$3.14
EPS (Diluted) i$6.74$5.39$5.91$5.45$3.07
Basic Shares Outstanding i68210007008000721800074230007768000
Diluted Shares Outstanding i68210007008000721800074230007768000

Income Statement Trend

CRA International Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i26.7M45.6M31.4M66.1M45.7M
Short-term Investments i-----
Accounts Receivable i162.3M142.7M143.6M117.0M111.6M
Inventory i-----
Other Current Assets-----
Total Current Assets i269.4M265.5M248.9M249.3M220.0M
Non-Current Assets
Property, Plant & Equipment i81.2M86.9M96.7M110.5M122.1M
Goodwill i194.7M195.2M194.4M182.1M183.5M
Intangible Assets i7.2M7.2M8.6M4.2M5.1M
Long-term Investments-----
Other Non-Current Assets25.8M16.3M11.4M10.8M12.4M
Total Non-Current Assets i302.1M287.7M302.1M306.0M338.5M
Total Assets i571.4M553.2M550.9M555.4M558.5M
Liabilities
Current Liabilities
Accounts Payable i28.2M28.7M27.6M23.5M19.4M
Short-term Debt i18.7M16.5M16.0M14.3M13.6M
Current Portion of Long-term Debt-----
Other Current Liabilities14.1M12.3M12.0M12.8M9.9M
Total Current Liabilities i251.3M236.1M217.1M213.1M200.1M
Non-Current Liabilities
Long-term Debt i84.5M92.3M106.0M124.5M139.4M
Deferred Tax Liabilities i1.2M1.1M953.0K1.0M725.0K
Other Non-Current Liabilities22.3M11.7M15.7M10.9M9.2M
Total Non-Current Liabilities i108.1M105.0M122.6M136.4M149.4M
Total Liabilities i359.4M341.1M339.8M349.5M349.5M
Equity
Common Stock i1.7M01.7M0503.0K
Retained Earnings i225.5M224.3M224.4M215.8M217.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i212.1M212.1M211.2M205.8M209.0M
Key Metrics
Total Debt i103.2M108.8M122.0M138.8M153.0M
Working Capital i18.1M29.4M31.7M36.3M19.8M

Balance Sheet Composition

CRA International Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i46.7M38.5M43.6M41.7M24.5M
Depreciation & Amortization i26.8M25.8M25.8M25.8M24.9M
Stock-Based Compensation i5.3M4.4M4.8M4.1M3.2M
Working Capital Changes i-15.9M-5.8M-48.5M17.1M-16.8M
Operating Cash Flow i60.0M58.3M25.8M89.1M37.1M
Investing Activities
Capital Expenditures i-16.6M-2.4M-3.8M-2.6M-17.1M
Acquisitions i-1.5M-577.0K-14.4M00
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-18.1M-2.9M-18.2M-2.6M-17.1M
Financing Activities
Share Repurchases i-33.3M-31.4M-27.6M-45.0M-13.4M
Dividends Paid i-12.3M-10.8M-9.6M-8.3M-7.5M
Debt Issuance i102.0M----
Debt Repayment i-102.0M-105.0M-126.0M-74.0M-77.0M
Financing Cash Flow i-48.9M-150.3M-166.4M-131.2M-98.7M
Free Cash Flow i33.1M57.7M21.3M73.1M37.6M
Net Change in Cash i-7.0M-95.0M-158.7M-44.7M-78.7M

Cash Flow Trend

CRA International Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.14
Forward P/E 24.88
Price to Book 6.37
Price to Sales 1.77
PEG Ratio 24.88

Profitability Ratios

Profit Margin 7.93%
Operating Margin 10.56%
Return on Equity 29.09%
Return on Assets 9.21%

Financial Health

Current Ratio 0.92
Debt to Equity 113.65
Beta 0.90

Per Share Data

EPS (TTM) $8.27
Book Value per Share $30.02
Revenue per Share $105.65

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
crai1.3B23.146.3729.09%7.93%113.65
Verisk Analytics 37.9B42.02121.47243.11%30.68%1,096.55
Equifax 30.5B48.256.0012.76%10.95%93.55
Icf International 1.8B17.111.8111.09%5.45%64.70
Diginex 1.4B-175.42197.13-114.37%-255.46%5.22
SBC Medical 420.1M12.781.7216.44%17.71%6.35

Financial data is updated regularly. All figures are in the company's reporting currency.